Skip to main content

4Front Ventures Corp.

FFNTFDelisted
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001783875

4Front Ventures Corp. was delisted in 2026; its insiders filed their last Form 4 on May 19, 2025; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by 4Front Ventures Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for 4Front Ventures Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for 4Front Ventures Corp.
NameTitleLast reported holdingLast filingFilings, past year
Kronberg MichaelSee Remarks–May 19, 20250
Krane KristopherDirector2,204,038Apr 22, 20250
Daily David RyanDirector2,204,038Apr 22, 20250
Gontmakher LeonidDirector43,801,636Apr 8, 20250
Gulati ChetanDirector21,734,345IndirectApr 8, 20250
Tkachenko RomanDirector14,534,655Apr 8, 20250
Thut AndrewChief Executive Officer23,084,778Dec 18, 20240
Chowscano KarlOther: Strategic Consultant31,271,401IndirectDec 18, 20240
Hunt Robert EDirector–Jul 9, 20240
Kampian PeterChief Financial Officer877,321IndirectMay 7, 20240
Frederick NicoleSee Remarks–Sep 27, 20230
Adams Keith EdwardOther: CFO–Jul 28, 20230
Patel Amit RamanlalDirector–Dec 9, 20220
Lentzsch Kathi PDirector–Nov 14, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 8, 2021 (view filing)Oct 62 daysGulati ChetanDirectorPPurchaseClass A Subordinate Voting Shares+9.71M$8,237,536.22+$80.0T–9.03M afterDerivative2 lotsPrice outlier
Jun 8, 2022 (view filing)Jun 62 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−47.0K$0.72−$33.8K−0.2%27.2M after
Jun 13, 2022 (view filing)Jun 103 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−300.0K$0.68−$204.0K−1.2%24.0M after
Jun 15, 2022 (view filing)Jun 13-142 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−169.0K$0.6699−$113.2K−0.7%23.8M after2 lots
Jun 17, 2022 (view filing)Jun 152 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−500$0.66−$3300.0%23.8M after
Jun 21, 2022 (view filing)Jun 174 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−7.50K$0.63−$4.72K0.0%23.8M after
Nov 14, 2022 (view filing)Jun 17150 daysAdams Keith EdwardChief Financial OfficerSSaleClass A Subordinate Voting Shares+1.00M$0.00$0–1.00M afterAmendedDerivative
Aug 30, 2023 (view filing)3:54 PM ETAug 291 dayGontmakher LeonidChief Executive OfficerPPurchaseClass A Subordinate Voting Shares+14.5K$0.125+$1.81K0.0%32.1M after
Sep 8, 2023 (view filing)2:17 PM ETSep 6-72 daysGontmakher LeonidChief Executive OfficerPPurchaseClass A Subordinate Voting Shares+95.0K$0.2278+$21.6K+0.2%41.5M after2 lots